Resources
Common myths about clinical trials
If you are looking into a colorectal cancer study for yourself or for someone you care for, much of what you have heard about research is outdated or flat wrong. These are five common myths.
Updated
Myth: once you sign, you cannot leave
The consent document is not a contract. You are free to walk away from a study whenever you choose, whatever your reason.
Myth: studies are only for people who are out of options
Trials are not tied to one stage. Different studies look for people at different points in a condition, and that holds for colorectal cancer research too. There are also studies that take people without the condition.
Myth: nobody is watching out for participants
No study goes unchecked. Before a colorectal cancer study can start, a committee that is independent of the researchers has to review it, and that review continues for as long as the study is running. Find out how review and monitoring work.
Myth: you will not be told what is going on
Before you agree to anything, the details are given to you in writing. If new information comes up later that could change your decision, the team is required to share it with you.
Myth: taking part means giving up your own doctor
Your own doctor stays your doctor in most studies. Make sure the study team and your doctor each know about the other.
Talk with a study coordinator
To find out which colorectal cancer studies may fit and what would come next, talk to a coordinator. Phone (888) 385-9581, or fill in the short form if you prefer. Questions are just questions: asking them commits you to nothing.
Sources and further reading
- About Research Participation — HHS Office for Human Research Protections
- Institutional Review Boards (IRBs) and Protection of Human Subjects in Clinical Trials — U.S. Food and Drug Administration
- Clinical Trials — MedlinePlus (National Library of Medicine)